Ad-hoc-Releases
-
There are no current ad hoc releases available.
-
2021‑05‑06 | DGAP-Ad-hoc
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
APONTIS PHARMA AG / Key word(s): IPO APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share 06-May-2021 / 20:07 CET/CEST Disclosure of a...
Read more...
Corporate News
-
There are no current corporate news available.
-
2021‑12‑16 | DGAP-News
APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO
DGAP-News: APONTIS PHARMA AG / Key word(s): Personnel 16.12.2021 / 07:30 The issuer is solely responsible for the content of this announcement. ...
Read more...2021‑12‑14 | DGAP-NewsAPONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with pan-Euro...
DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch/Alliance 14.12.2021 / 07:30 The issuer is solely responsible for the content of this announ...
Read more...2021‑11‑18 | DGAP-NewsAPONTIS PHARMA grows significantly faster than the overall market in the nine-month period 2021 - Re...
DGAP-News: APONTIS PHARMA AG / Key word(s): Quarterly / Interim Statement/9 Month figures 18.11.2021 / 07:30 The issuer is solely responsible for the ...
Read more...2021‑10‑26 | DGAP-NewsAPONTIS PHARMA announces market launch of new Single Pill
DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch 26.10.2021 / 07:30 The issuer is solely responsible for the content of this announcement.
2021‑09‑14 | DGAP-NewsAPONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and ...
DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch 14.09.2021 / 07:30 The issuer is solely responsible for the content of this announcement.
2021‑08‑11 | DGAP-NewsAPONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary figur...
DGAP-News: APONTIS PHARMA AG / Key word(s): Half Year Results/Half Year Report 11.08.2021 / 07:30 The issuer is solely responsible for the content of ...
Read more...2021‑07‑28 | DGAP-NewsAPONTIS PHARMA reports accelerated growth in first half of 2021 - Single Pill revenues +83% to EUR 1...
DGAP-News: APONTIS PHARMA AG / Key word(s): Preliminary Results/Half Year Results 28.07.2021 / 07:30 The issuer is solely responsible for the content ...
Read more...2021‑07‑12 | DGAP-NewsAPONTIS PHARMA marks further success in the roll-out of Single Pill therapy
DGAP-News: APONTIS PHARMA AG / Key word(s): Alliance 12.07.2021 / 07:30 The issuer is solely responsible for the content of this announcement. ...
Read more...2021‑06‑18 | DGAP-NewsAPONTIS PHARMA AG: Initial studies confirm that the share has a price potential of between 77% and 1...
DGAP-News: APONTIS PHARMA AG / Key word(s): Research Update 18.06.2021 / 07:30 The issuer is solely responsible for the content of this announcement.<...
Read more...2021‑06‑10 | DGAP-NewsAPONTIS PHARMA AG: Post-Stabilisation disclosure - Partial exercise of the Greenshoe Option
DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 10.06.2021 / 21:23 The issuer is solely responsible for the content of this announcement.
2021‑06‑10 | DGAP-NewsAPONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 10.06.2021 / 21:20 The issuer is solely responsible for the content of this announcement.
2021‑05‑28 | DGAP-NewsAPONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 28.05.2021 / 20:05 The issuer is solely responsible for the content of this announcement.
2021‑05‑20 | DGAP-NewsAPONTIS PHARMA AG Trading Update: Strong revenues and earnings growth with Single Pills continues i...
DGAP-News: APONTIS PHARMA AG / Key word(s): Quarterly / Interim Statement 20.05.2021 / 07:30 The issuer is solely responsible for the content of this ...
Read more...2021‑05‑19 | DGAP-NewsAPONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 19.05.2021 / 20:23 The issuer is solely responsible for the content of this announcement.
2021‑05‑14 | EQS-NewsApontis Pharma (APPH): Initiation - A phoenix rises
Edison Investment Research Limited 14-May-2021 / 07:00 GMT/BST
Financial Calendar
-
Mar 30, 2022
Annual Report 2021 + Earnings Call
Apr 04, 2022CF&B SmallCap Event (April 4 - 5, 2022)
ParisMay 03, 2022MKK – Münchner Kapitalmarkt Konferenz (May 3 - 4, 2022)
MunichMay 11, 2022Trading Update 3M/Q1 2022 + Earnings Call
May 12, 2022Annual General Meeting
May 18, 2022PLATOW Euro Finance Small Cap Conference
Frankfurt (Main)August, 2022Half-year Report 2022 + Earnings Call
Sep 05, 2022German Fall Conference (September 5 - 6, 2022)
Frankfurt (Main)Oct 17, 2022CF&B European MidCap Event (October 17 - 18, 2022)
ParisNovember, 2022Trading Update 9M/Q3 2022 + Earnings Call
Nov 28, 2022EKF Deutsches Eigenkapitalforum (November 28 - 30, 2022)
Frankfurt (Main) -
February, 2021
2020 Annual Report
April, 2021Annual General Meeting 2021
Jul 28, 2021Preliminary half-year figures
Aug 11, 2021Publication of half-year financial statements / Conference call 14.00 CST
Aug 26, 2021Hamburger Investorentag (HIT)
HamburgSeptember, 2021Roadshow
Sep 06, 2021Equity Forum German Fall Conference
Frankfurt/MainNov 18, 2021Quarterly Statement 9M 2021
Nov 22, 2021German Equity Forum
Frankfurt/Main
Managers' Transactions
-
There are no current managers’ transactions available.
-
There are no current managers’ transactions available.
Other mandatory notifications
There are no other mandatory notifications available.
